Daily Stock List
ForeverGreen Worldwide Corp. (FVRG)
Stock Market Media Group reported recently on ForeverGreen Worldwide Corp. (FVRG), PennyStocks24, Secret Stock Club, StocksGoneWild, Stock Twiter, StockHideout, Perfect Penny Stocks, Penny Champions, Stock Roach, Penny Dreamers, OTCEquity, and EpicVIP Group reported earlier, and today we highlight the Company, here at the QualityStocks Daily Newsletter.
ForeverGreen Worldwide Corp. is a leading provider of nutritional foods and other healthy products. Listed on the OTC Bulletin Board, the Company develops, manufactures, and distributes an extensive line of all natural whole foods and products to North America, Australia, Europe, Asia, South America, and Africa. ForeverGreen launched in May of 2004. They manufacture their own products. ForeverGreen Worldwide has their corporate headquarters in Orem, Utah.
A total lifestyle company, ForeverGreen Worldwide focuses on bringing their worldwide members and customers the best of science and nature via innovative formulations of whole-food and/or safe ingredients. The Company believes they are part of a recession-proof industry where home-based businesses and prevention are growing. Their product line offers restoration support in the Cardio, Immune, Weight Management, Beauty and Skin Care, Natural Energy, Physical Fitness, and overall General Health areas.
ForeverGreen Worldwide’s offerings include their PowerStrips. In addition, they offer Azul and FrequenSea™ whole-food beverages with industry exclusive Marine Phytoplankton; the Versativa line of hemp-based whole-food products; A.I.M. Transfer Factor immune support; 03World™ weight management products; Pulse-8 powdered L-arginine formula; TRUessence™ Essential Oils and Apothecary, and 24Karat Chocolate®. They also offer a complete catalog of meals, snacks, household cleaners, as well as personal care products.
Last month, the Company announced that the number of distributors of the new FGXpress brand is greater than 15,000 and increasing by approximately 100 daily. Mr. Ron Williams, Chief Executive Officer, commented, “We have added over 5,000 new distributors during the last 60 days. We are currently adding nearly 3,000 distributors per month and expect this number to continue to increase as we move forward. We have customers in 136 countries and are experiencing growth in nearly all geographic regions.”
In addition, in September, ForeverGreen Worldwide announced that they hired a new Chief Financial Officer (CFO), Mr. Jack B. Eldridge. Mr. Eldridge received his undergraduate degree in accounting and graduated with a Master of Business Administration (MBA). He is a licensed Certified Public Accountant (CPA); he was Director of Finance/International Controller for Neways International for 10 years. Moreover, he has broad international experience with a number of large companies, including Novell and Rio Tinto.
ForeverGreen Worldwide Corp. (FVRG), closed Monday's trading session at $1.47, up 10.36%, on 76,326 volume with 48 trades. The average volume for the last 60 days is 29,177 and the stock's 52-week low/high is $0.06/$1.40.
Coates International Ltd. (COTE)
Wallstrettlivechat, OTCPicks, FeedBlitz, and SmallCapVoice reported earlier on Coates International Ltd. (COTE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Coates International Ltd. is a precision engineering company with corporate headquarters in Wall Township, New Jersey. They specialize in the development of technologies that evolve the standard combustion engine with the objectives of noticeably improving fuel efficiency and power generation, and reducing harmful emissions and long-term maintenance costs. Organized on December 22, 1987 and reorganized in 1991, Coates International’s shares trade on the OTCQB.
The Company involves in the development of the Coates Spherical Rotary Valve (CSRV) System. The CSRV system technology is used in piston-driven internal combustion engines. The design of the CSRV system technology is to replace the intake and exhaust conventional poppet valves used in piston-driven stationary, automotive, motorcycle, and marine engines.
Coates CSRV system technology is used in diverse applications. These include engines for electric power generators for home use, industrial complexes, and grid installations; and engines to power motorcycles, automobiles, light trucks, heavy trucks, machinery, railroads, marine engines, military equipment, light aircraft, helicopters, lawn mowers, snowmobiles, jet skis, and more.
The CSRV contains two spherical rotary valves assembled on two separate shafts. One is for inlet and one for exhaust. They rotate on ceramic carbon bearing with no oil lubrication. The spheres do not make contact with any part of the housing. The seals are a floating kind and consist of a ceramic material. They have two piston rings and are floating in a small cylinder-type chamber. They are activated by the compression and the combustion strokes of the engine; this allows 100 percent sealing effectiveness, upon compression.
Last Friday, Coates International announced that they signed a preliminary agreement with the Chinese Government on Thursday, October 3, 2013 to establish large industrial engine and generator manufacturing plants in China to mass produce the Company’s CSRV Products. The total investment is approximately USD$1,500,000,000. In addition, there are two other Chinese companies in this deal of which Coates International already executed Letters Of Intent (LOI) and confidentiality with.
Coates International Ltd. (COTE), closed Monday's trading session at $0.0795, up 32.50%, on 670,583 volume with 48 trades. The average volume for the last 60 days is 134,643 and the stock's 52-week low/high is $0.0106/$0.12.
The Pulse Network, Inc. (TPNI)
Pumps and Dumps, PennyStocks24, SmallCapVoice, Liquid Pennies, Stockhunter.us, HEROSTOCKS, VIP STOCK ALERTS, Stock Brain, OTCBB Journal, First Penny Picks, PennyStockSpy, OO7 Stock Chat, AimHighProfits, Stock Roach, StockHideout, VIP Penny Stocks, Winston Small Cap, OTCEquity, and OTCMagic reported this month on The Pulse Network, Inc. (TPNI), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
Based in Canton, Massachusetts, The Pulse Network, Inc. provides a cloud-based platform concentrating on content marketing and event solutions. Additionally, the Company produces their own branded content programs including online video productions. Furthermore, The Pulse Network produces the Inbound Marketing Summit conference series that currently runs in New York, San Francisco, and Boston, and the Digital Pulse program which currently runs in Boston. The Pulse Network lists on the OTC Bulletin Board.
The Company assists clients - ranging from Fortune 500 companies to small and mid-size companies - in increasing awareness, propelling lead generation, and improving client engagement via content and inbound marketing, social strategy, campaign management, and event registration and event marketing activities in the U.S. with a social and digital foundation. The Pulse Network offers a service to businesses to create a platform for delivering content, chiefly video, and written and curated content, integrated with digital, social media, and offline event strategies.
Their platform allows digital and event marketers to fast-track their social strategy and create engaging content; event organizers to drive audience and engagement; and public relations companies and professionals to reach targeted audiences with The Pulse Network’s original content.
In August, The Pulse Network and The National Fire Protection Association announced the development of an online community where members of the electrical community and others interested in electrical issues can find news, information, tips, learning resources, and networking opportunities related to NFPA 70(R), National Electrical Code(R) (NEC(R)). The new online community is at necconnect.org. It is a resource for installers and contractors, designers and engineers, code enforcers, and policy makers for all things related to the NEC. It is a destination where participants can involve with others who share an interest in electrical safety.
Last month, The Pulse Network, in cooperation with SAP, announced the Customer Edge outpost. The Customer Edge is a new multimedia resource for everything related to delivering engaging, profitable customer relationships - for marketers, sales professionals, and service executives. The Customer Edge has exclusive video content, feature articles, social feeds, as well as conversations. SAP is the market leader in enterprise application software.
The Pulse Network, Inc. (TPNI), closed Monday's trading session at $0.38, up 11.76%, on 287,410 volume with 101 trades. The average volume for the last 60 days is 25,137 and the stock's 52-week low/high is $0.10/$3.00.
Aspen Group, Inc. (ASPU)
RedChip reported earlier on Aspen Group, Inc. (ASPU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Aspen Group, Inc. is an online post-secondary education company. The Company owns Aspen University, Inc., a nationally accredited, online post-secondary education company formed in 1987. Aspen University’s mission is to become an institution of choice for adult learners through providing cost-effective, comprehensive, as well as relevant online education. Their focus is on offering the highest quality degrees at the lowest possible cost per credit. Aspen Group has their corporate headquarters in Denver, Colorado.
Aspen University is nationally accredited by the Accrediting Commission, Distance Education and Training Council (DETC). The Accrediting Commission of the Distance Education and Training Council is listed by the U.S. Department of Education as a nationally recognized accrediting agency, and is a recognized member of the Council for Higher Education Accreditation.
Aspen University is a publicly-traded, exclusively online, for-profit university, and 86 percent of Aspen full-time degree-seeking students, as of July 31, 2013, are enrolled in a graduate degree program (Master's or Doctoral degree program). In addition, 61 percent of Aspens’ adjunct faculty holds Doctoral degrees. Aspen Group operates Aspen University as a wholly owned subsidiary. Aspen University was the first accredited institution to offer an online Master of Business Administration (MBA).
Aspen University offers students 65 degree programs, specializations, completion programs, as well as certificates. These are in a wide spectrum of areas such as business and organization management, education, nursing, information technology (IT), general studies and others.
Aspen University’s Master of Science in Nursing Program is accredited by the Commission on Collegiate Nursing Education (CCNE). In addition, Aspen University is a Global Charter Education Provider for the Project Management Institute (PMI). Their Project Management Program has been reviewed and approved by the PMI, and it prepares the student to take the Project Management Professional (PMP®) Certification exam, if they so desire.
Aspen Group, Inc. (ASPU), closed Monday's trading session at $0.191, down 3.33%, on 279,800 volume with 14 trades. The average volume for the last 60 days is 33,641 and the stock's 52-week low/high is $0.195/$1.24.
Spindle, Inc. (SPDL)
Today we are reporting on Spindle, Inc. (SPDL), here at the QualityStocks Daily Newsletter.
Headquartered in Scottsdale, Arizona, Spindle, Inc. is a foremost provider of white-label mobile payment solutions for banks, financial institutions, telecommunication innovators, and merchants seeking to offer secure, flexible, and cost-effective mobile commerce services to their customers. The Company’s commitment is to expanding beyond traditional electronic payment boundaries through offering innovative solutions, which allow clients, partners, merchants, and consumers to make the best use of the fast emerging mobile economy. Founded in 2011, Spindle lists on the OTC Markets’ OTCQB. The Company also has offices in Texas, Florida, Colorado, and Utah.
Spindle has a wide-ranging proprietary intellectual property (IP) portfolio (which include patents pending) that cover networks, mobile payments, and security. Spindle delivers their products as a standalone solution or in tandem with existing payment, acquiring, and acceptance offerings to create a strong, multi-functional mobile commerce ecosystem.
Their merchant solutions include a mobile merchant platform; cloud POS solutions; eCommerce payment solutions, and check services (ACH and Check Imaging). Consumer Solutions include mobile wallet; and loyalty, offers and couponing. Managed Services include PSP/PF servicing; payments infrastructure, and cloud POS integration.
In late September, Spindle announced that the Company entered an agreement with MerchantPlus. MerchantPlus is a registered ISO and MSP (MasterCard service provider) for Wells Fargo Bank. MerchantPlus will integrate Spindle's PSP payment solution into their NaviGate processing gateway for eCommerce and mobile transaction and incorporate a branded, Spindle-hosted "Apply Now" button into their website. MerchantPlus is a leading payment gateway and independent sales organization (ISO) based in New York City's financial district.
Today, ValidSoft, announced that they have integrated their secure mobile commerce technology with Spindle's new "MeNetwork360" mobile commerce ecosystem being previewed at the Money2020 conference taking place from October 6 to October 10, 2013 in Las Vegas, Nevada. ValidSoft is a worldwide supplier of advanced telecommunications-based fraud prevention, authentication and transaction verification solutions, and a wholly owned subsidiary of Elephant Talk Communications Corp. (ETAK).
Spindle, Inc. (SPDL), closed Monday's trading session at $1.26, up 20.00%, on 85,835 volume with 60 trades. The average volume for the last 60 days is 39,947 and the stock's 52-week low/high is $0.312/$3.00.
Adamis Pharmaceuticals Corp. (ADMP)
The Online Investor, AllPennyStocks, SeriousTraders, FeedBlitz, SmallCapVoice, Microcap Money, and Triple Crown Stocks reported earlier on Adamis Pharmaceuticals Corp. (ADMP), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
A biopharmaceutical company, Adamis Pharmaceuticals Corp. engages in the development and commercialization of specialty pharmaceutical and biotechnology products in the therapeutic areas of respiratory disease, allergy, oncology, and immunology. The Company owns Intellectual Property (IP) relating to an antimicrobial and contraceptive product candidate called C31G. The focus of their biotechnology efforts are on the development of therapeutic vaccine product candidates and cancer drugs for patients with unmet medical needs in the multi-billion dollar worldwide cancer markets. Adamis Pharmaceuticals’ shares trade on the OTCQB; the Company is based in San Diego, California.
Adamis Pharmaceuticals presently has four product candidates in their specialty pharmaceutical product pipeline, in addition to the C31G technology. These include the Epinephrine Injection PFS syringe product for use in the emergency treatment of anaphylaxis; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease, and APC-3000, an HFA inhaled nasal steroid product for the treatment of allergic rhinitis.
The Company’s products under research and development include TeloB-VAX, a novel cell-based therapeutic cancer vaccine. They also include three drugs, APC-100, APC-200, and APC-300, for the treatment of prostate cancer.
This past August, Adamis announced that they received an allowance in the United States for a patent application relating to one of their prostate cancer compounds. The same month, the Company also announced the exclusive license of a dry powder inhaler technology.
Recently, Adamis Pharmaceuticals announced that a recently published study conducted by university researchers found that their antimicrobial and spermicidal agent, C31G, was effective in treating Herpes Simplex Virus (HSV) in an eye infection (ocular keratitis) animal model. Adamis earlier reported that C31G successfully completed a Phase 3 contraceptive clinical trial in humans conducted by the National Institute of Child Health and Human Development.
The Company indicates that C31G is an effective spermicide and broad-spectrum antibacterial agent. In previous studies it has shown activity against gram-positive and gram-negative organisms, including chlamydia, and a range of antibiotic resistant strains.
Adamis Pharmaceuticals Corp. (ADMP), closed Monday's trading session at $0.36, up 16.13%, on 89,903 volume with 35 trades. The average volume for the last 60 days is 92,977 and the stock's 52-week low/high is $0.31/$1.10.
Petro River Oil Corp. (PTRC)
PennyStocks24 reported earlier on Petro River Oil Corp. (PTRC), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Petro River Oil Corp. is an independent exploration and production company. They focus on their oil properties in the Mississippi Lime play in eastern Kansas. The Mississippi Lime play covers approximately 17 million acres in Oklahoma and Kansas, in comparison to 10- to 15 million acres in the Bakken and 6 million in the Eagle Ford. Petro River Oil has accumulated nearly 100,000 acres with an extensive inventory of low cost, high return development drilling opportunities.
Petro River Oil completed a number of related transactions through which they acquired control of Petro River Oil, LLC (Petro LLC) and Petro’s wholly-owned subsidiary Petro River Operating, LLC. Petro River Oil has their headquarters in Houston, Texas. Founded in 2011, the Company lists on the OTC Bulletin Board.
Petro River Oil’s particular objectives include increasing production by developing their acreage; increasing profitability margins by evaluating and optimizing their production, and executing their business plan to increase property values, reserves, and expanding their asset base. The Company also has considerable acreage and oil reserves in the State of Missouri. Their current Oil and Gas portfolio consists of 60,105 gross/40,591 net acres in Missouri, Kentucky, and Montana.
Petro LLC is an emerging oil and gas producer that controls a substantial acreage position in the Southeast Kansas region of the Mississippi Lime formation. Due to the acquisition of Petro River Oil, the Company has added 115,000 gross/85,000 net acres to their Oil and Gas portfolio. This includes five producing oil and gas wells in which Petro owns a 50 percent Working Interest (WI) and a 40 percent Net Revenue Interest (NRI).
This has established a major presence in the Mississippi Lime play. This acreage is in addition to the Company's present Oil and Gas portfolio. Petro River Oil has also acquired more than 60 square miles of proprietary 3D seismic data over prospective Mississippi Lime acreage in the same area. As part of this acquisition, WI’s in leases in which Petro River Oil already has a stake were acquired from Mega Partners I for approximately 15.5mm shares.
Petro River Oil is concentrating on developing their recently acquired Mississippi Lime acreage in Kansas and also their heavy oil properties in Missouri and Kentucky. Early reservoir projects in Kansas were focused on proving reserve potential into the Bourbon Arch geological region of the Mississippi Lime play. The production response from this region established migration and asset production potential.
Furthermore, Petro River Oil engaged an extensive geologic study of the Company’s leasehold position using more than 26,000 producers and 40 acres of a proprietary 3D data set. Their intention is to raise capital to drill several prospective reserve targets.
Petro River Oil Corp. (PTRC), closed Monday's trading session at $0.122, down 2.40%, on 738,574 volume with 99 trades. The average volume for the last 60 days is 297,007 and the stock's 52-week low/high is $0.0052/$0.56.
BioZone Pharmaceuticals, Inc. (BZNE)
We are reporting on BioZone Pharmaceuticals, Inc. (BZNE) today, here at the QualityStocks Daily Newsletter.
Formed in 1987 by Dr. Brian Keller, BioZone Pharmaceuticals, Inc. is a developer, manufacturer, and marketer of Over-the-Counter (OTC) drugs and preparations, cosmetics, and nutritional supplements. This is on behalf of health care product marketing companies and national retailers. BioZone Pharmaceuticals is based in Englewood Cliffs, New Jersey. The Company’s shares trade on the OTC Markets’ OTCQB.
On May 16, 2011, BioZone acquired substantially all of the assets and assumed all of the liabilities of Aero, pursuant to an Asset Purchase Agreement dated as of that date. Aero manufactures, markets, and distributes a line of dermatological products under the trade name of Baker Cummins Dermatologicals. On June 30, 2011, BioZone acquired the BioZone Lab Group, which operates as a developer, manufacturer, and marketer of OTC drugs and preparations, cosmetics, and nutritional supplements.
BioZone has developed proprietary drug delivery technology (the BioZone Technology) as an enhancement for approved generic prescription drugs that are limited because of poor stability or bioavailability or variable absorption. The proprietary drug delivery technology has enabled and transformed the administration of drugs that are difficult to formulate.
BioZone Pharmaceuticals’ products include Cosmetic and Personal Care Products, such as creams, lotions, gels, ointments, cleansers, toners, masks, eye treatments, lip treatments, moisturizers, sun protection, and acne products. Products additionally include Nasal and Ear Products, including drops, sprays, liquids, lotions, and gels. Furthermore, products include Dietary Supplements including liquids, suspensions, syrups, solutions, as well as gels.
The application of BioZone's technology allows them to pursue reformulation of generic drugs and pursue a low-risk regulatory pathway for NDA approval. BioZone also provides oral, topical, and injectable drug products for anesthesia, infectious diseases, metabolic diseases, and oncology. They offer an innovative line of dermatology products for a variety of dermatological diseases.
The Company’s patented technologies include QuSomes® and LipoSpray®. QuSomes are new, revolutionary, non-phospholipid liposomes. They are suitable for cosmetic and drug formulation that render conventional liposomes obsolete. LipoSpray® is a new patented delivery technology. LipoSpray® enhances the absorption of active ingredients when sprayed into the mouth under the tongue. The liposome encapsulated active ingredients penetrate the mucosal tissue of the mouth. They are absorbed into the bloodstream and circulate throughout the body in minutes.
Earlier this month, MusclePharm Corp. (MSLP) announced that they made a $2 million strategic investment in BioZone Pharmaceuticals. MusclePharm develops and markets sports nutritional supplements that address active lifestyles.
BioZone Pharmaceuticals, Inc. (BZNE), closed Monday's trading session at $0.50, up 3.95%, on 2,076,584 volume with 363 trades. The average volume for the last 60 days is 477,800 and the stock's 52-week low/high is $0.16/$3.75.
First Titan Corp. (FTTN)
The QualityStocks Daily Newsletter would like to spotlight First Titan Corp. (FTTN). Today, First Titan Corp. closed trading at $1.01, even for the day, on 30,910 volume with 34 trade. The stock’s average daily volume over the past 60 days is 65,564, and its 52-week low/high is $0.29/$5.49.
First Titan Corp. reported today on how, following months of due diligence, the company is now on the verge of acquiring a key working interest in an area of immense production potential in Southeast Texas, Hardin County. The target acquisition includes several wells located on over 4,100 leased acres and it possesses potential production from one zone that could be across several wells, drastically increasing production in the short term with relatively minimal capital.
First Titan Corp. (FTTN), is currently focused on exploring and developing oil and natural gas resources in the southern region of the United Sates, but has a worldwide growth strategy in place. The company continually seeks to partner with energy developers that are pursuing innovative new methods of oil and gas extraction, including the development of new technologies, cleaner methods, and unconventional resources.
First Titan has acquired multiple working interests with established oil exploration companies to deliver new hydrocarbons to an ever-growing market. As the company maintains drilling activities at its acquisition in South Lake Charles, Louisiana, it is looking to continue adding to its asset base that includes five new wells along the Gulf Coast, from West Texas to Alabama.
Global demand for energy is rising fast as the vehicle populations of emerging nations such as China, Brazil, and India continue to soar. U.S. exports of petroleum products have reached 2.6 million barrels a day, which is double the level of three years ago. As demand for global energy resources rises, the U.S. is poised to become an international supplier.
New innovations in drilling and rising global demand have positioned First Titan as a premier early-stage company with strong growth potential. By utilizing cutting-edge technology to extract oil and gas resources, the company is able to recover fossil fuels that were once considered too difficult or too expensive to recover. Disclaimer
First Titan Corp. Company Blog
First Titan Corp. News:
FTTN Nears Completion of Lucrative New Acquisition
FTTN Indicates Evaluation of Major Merger Opportunities & Provides Drilling Update
FTTN Expanding Acquisition Focus in Southeast Texas
On the Move Systems, Inc. (OMVS)
The QualityStocks Daily Newsletter would like to spotlight On the Move Systems, Inc. (OMVS). Today, On the Move Systems, Inc. closed trading at $0.13, off by 7.14%, on 499,094 volume with 52 trades. The stock’s average daily volume over the past 60 days is 136,603, and its 52-week low/high is $0.0027/$0.403.
On The Move Systems Corp. reported that they are currently finalizing a business development agreement with the Naples Connection, a Florida-based provider of travel and transportation services today. Once an agreement can be struck, the Naples Connection, which delivers online deals on flights, cruises, hotels and travel, making the company a natural partner for OMVS as the company prepares to launch its new online transportation portal, could soon be OMVS’ first partner to share in charter, travel and cargo revenues, beginning with transport to the Bahamas.
On the Move Systems, Inc. (OMVS) has established a scalable business model for leveraging the available routes and “legs” of private aviation to book private air charter, freight, and animal/exotic transport services. Their unique ISTx software is designed for managing and supporting services and routes across multiple private/commercial carriers through this single platform.
Management places strong emphasis on customer satisfaction and approaches this viewpoint by creating a unique flight or service profile for each client. The company has developed a business model offering this profile access through various proprietary and membership models. Additionally, its business strategy incorporates acquiring or joining with smaller charter plane owners. The company has further established various divisions which address particular client needs and routes. Leveraging its unique business model with a host of innovative solutions for expanding markets, OMVS is well positioned for rapid growth.
Current divisions of OMVS include Charter Services, Inter-Modal Freight, and Animal/Exotic Transport. The Charter Services Division offers private charter airplane owners the opportunity to enter a network where available planes will be "on-call" to deliver private air charter service on demand. The Inter-Modal Freight Division provides charter and freight shipping services to clients who need to expedite shipment of cargo and freight globally – including medical transport for tissue and isotopes. The company's Animal/Exotic Transport Division affords clients the security of transporting pets and animals without the accompaniment of the owner.
OMVS continues to develop technology and applications that connect all business touch points - passengers, assets, and routes. The company intends to monitor daily operations through a single platform providing ultimate support for all business activities. OMVS is in the final stages of development with the ISTx platform and plans to implement system wide in the next two fiscal quarters. Disclaimer
On the Move Systems, Inc. Company Blog
On the Move Systems, Inc. News:
OMVS Negotiates New Referral Agreement to Jump-Start Revenues
OMVS Moves Forward with Luxury Transportation Agreement
OMVS Grows Industry Network
Sohm, Inc. (SHMN)
The QualityStocks Daily Newsletter would like to spotlight Sohm, Inc. (SHMN). Today, Sohm, Inc. closed trading at $0.0049, even for the day. The stock’s average daily volume over the past 60 days is 215,407, and its 52-week low/high is $0.0027/$0.013.
Sohm, Inc. announced today that they have agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs and Message Boards. QualityStocks, based in Scottsdale, Arizona, is a free service (Sign Up Here) that collates data from hundreds of Small-Cap online Investment Newsletters into one Daily Newsletter Report and is dedicated to assisting emerging public companies with their investor communication efforts.
Sohm, Inc. (SHMN) is a globally recognized pharmaceutical manufacturer that develops, manufactures, and distributes generic, private label, and Sohm-innovated pharmaceutical, cosmeceutical, and nutraceutical products. The company exports product worldwide, with a focus on distribution in emerging markets such as Africa, Latin America, and Southeast Asia.
In 2012, Sohm was voted the fastest growing generics prescription drug manufacturer at the 30th All India Conference of National Integrated Medical Association. Committed to being a global leader in improving the health and quality of people’s lives in every corner of the world, the company has U.S. headquarters in Buena Park, CA, with international headquarters located in Ahmedabad, India, and several corporate offices located within the UK and China.
Research and development activities capitalize on the company’s expertise in numerous drug delivery technologies, including solid dosage form, oral-controlled and sustained releases semi-solid, liquid, oral transmucosal, transdermal, gel, injectable, and other drug delivery technologies, as well as the application of these technologies to proprietary drug forms.
To ensure regulatory compliance, the company continuously assesses and monitors the output of the existing quality systems, and application of evolving industry guidelines and regulations. Leveraging a global presence, an expanding drug portfolio that covers all major treatment categories, and a respected brand, Sohm is well positioned to continue its rapid growth.. Disclaimer
Sohm, Inc. Company Blog
Sohm, Inc. News:
SOHM, Inc. Announces Engagement of QualityStocks Investor Relations Services
SOHM Launches a Unique Protein Supplement First Time in India
SOHM Announces First Quarter 2013 Financial Results
Boston Therapeutics, Inc. (BTHE)
The QualityStocks Daily Newsletter would like to spotlight Boston Therapeutics, Inc. (BTHE). Today, Boston Therapeutics, Inc. closed trading at $1.40, up 27.27%, on 112,500 volume with 66 trades. The stock’s average daily volume over the past 60 days is 10,756, and its 52-week low/high is $0.15/$1.30.
Boston Therapeutics, Inc. (BTHE) is a pharmaceutical company focused on the development and commercialization of novel compounds based on complex carbohydrate chemistry to address unmet medical needs. An IP portfolio solidifies the company's position in the pharmaceutical industry. Boston Therapeutics' current product pipeline, PAZ320 and IPOXYNT, is comprised of therapies developed to treat patient populations with Type 2 diabetes.
PAZ320 is a non-systemic, non-toxic, chewable drug candidate for prevention of diabetes and its complications. PAZ320 inhibits the enzymes that release glucose from complex carbohydrate in foods during digestion. Boston Therapeutics believes PAZ320 is a safe and effective drug compound for people with pre-diabetes and diabetes in their daily management of blood glucose levels, fulfilling an unmet medical need. PAZ320 has completed a Phase ll clinical trial at Dartmouth Medical Center. 45% of the patients responded with a 40% reduction in the elevation of post meal blood sugar compared to baseline with no serious adverse events.
IPOXYNT, a universal oxygen carrier, is an injectable Rx for prevention of necrosis and treatment of ischemic conditions which may lead to necrosis. This compound is not a biologic, but a second generation New Chemical Entity HBOC (hemoglobin based oxygen carrier). The potential for this product goes well beyond Lower Limb Ischemia into a range of areas from anemia and blood loss (injury), to cardiovascular disease and surgical blood supplementation.
The Boston Therapeutics management and advisory team has extensive expertise in complex carbohydrate chemistry, regulatory affairs, and clinical development, with multiple submissions and approvals to U.S. Food and Drug Administration. Backed by a team with more than five decades of expertise in public and private business management, the company is well positioned to advance its status as a premier developer of complex carbohydrate-based new chemical entities. Disclaimer
Boston Therapeutics, Inc. Company Blog
Boston Therapeutics, Inc. News:
Boston Therapeutics Closes $5.3 Million in Private Placement of Common Stock and Warrants
Boston Therapeutics Closes on Approximately $3.5 Million in Private Placement of Common Stock and Warrants
Boston Therapeutics Reports Positive Phase II Results of PAZ320 Are Published in July/August Issue of Endocrine Practice
CD International Enterprises, Inc. (CDII)
The QualityStocks Daily Newsletter would like to spotlight CD International Enterprises, Inc. (CDII). Today, CD International Enterprises, Inc. closed trading at $0.09, up 20.00%, on 679,977 volume with 53 trades. The stock’s average daily volume over the past 60 days is 61,410, and its 52-week low/high is $0.041/$0.205.
CD International Enterprises, Inc. (CDII) is a U.S. based company that produces, sources, and distributes industrial commodities in China and the Americas, in addition to providing business and financial consulting services. Headquartered in Deerfield Beach, Florida, with corporate offices in Shanghai, CD International Enterprises’ unique infrastructure provides a platform to expand business opportunities globally.
Through its wholly owned subsidiary, International Magnesium Group, CD International Enterprises owns and operates one of the leading producers of magnesium in the world. International Magnesium Group sources its magnesium from six production facilities in the People's Republic of China, with a combined annual production and distribution capacity of approximately 80,000 metric tons of magnesium ingots and 10,000 metric tons of magnesium powder.
CD International Enterprises also sources, aggregates, and distributes iron ore, manganese ore, and scrap metals for companies located throughout the People’s Republic of China via wholly owned subsidiary CDII Minerals. The scope of CDII Minerals’ services include: purchasing, financing, logistics, quality control, in addition to conducting comprehensive legal, financial, and technical due diligence on suppliers.
The company’s management team possesses the necessary leadership expertise and a solid working knowledge of the unique characteristics of business operations in the U.S., China, Mexico, and South America. Employing a global growth strategy, CD International Enterprises has the unique ability to identify emerging market opportunities and provide comprehensive solutions or services relevant to conducting cross border business. Disclaimer
CD International Enterprises, Inc. Company Blog
CD International Enterprises, Inc. News:
Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of CD International Enterprises, Inc.
CD International Enterprises and Minera MAPSA S.A. Partner to Explore Iron Ore Mining, Distribution and Facilities Opportunities in Peru
CD International Enterprises Expands Its Ore Distribution Business into Ecuador by Beginning Delivery of 10,000 Metric Tons of Ecuadorean Iron Ore to Major Chinese Trading Company
Singlepoint, Inc. (SING)
The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0055, up 12.24%, on 1,655,076 volume with 15 trades. The stock’s average daily volume over the past 60 days is 2,056,003, and its 52-week low/high is $0.0025/$0.03.
Singlepoint, Inc. (SING) is a state-of-the-art mobile technology company and full-service mobile marketing agency. The company’s mobile commerce and communication platform allows clients to conduct business transactions, accept donations, and engage in targeted communication campaigns with their customers/donors through mobile devices.
The company is known for making any campaign instantly interactive via the mobile phone, enabling non-profit and for-profit organizations send more messages, create more awareness, and raise revenues and donations. The SinglePoint brand has been associated with media messaging campaigns for NBC, MTV, CBS, Univision and other top corporate entities.
Today, approximately 150 million web-enabled mobile phones exist in our nation alone. Javelin Strategy and Research predicts the highest growth for any payment type from now until 2018 will be in mobile payments. Rapid mobile adoption and the industry-wide push for mobile payments are anticipated to increase the total amount of mobile payments at point of sale to $5.4 billion in 2018.
SinglePoint is well positioned to capitalize on the growing mobile technology space. Key partnerships with companies such as Text2Bid, a leader in mobile auction technology, solidify the company’s foothold in the industry and provide multiple avenues for ongoing expansion. Moving forward with a solid business plan and carefully assembled management team, SinglePoint is poised for rapid growth. Disclaimer
Singlepoint, Inc. Company Blog
Singlepoint, Inc. News:
Singlepoint, Inc. Announces Engagement of QualityStocks Investor Relations Services
Singlepoint, Inc. Secures Partnership, Sales Rights with Mobile Auction Expert, Text2Bidâ„˘
SinglePoint, Inc. Partners with iATS Payments
Advaxis, Inc. (ADXS)
The QualityStocks Daily Newsletter would like to spotlight Advaxis, Inc. (ADXS). Today, Advaxis, Inc. closed trading at $4.53, up 1.12%, on 43,265 volume with 80 trades. The stock’s average daily volume over the past 60 days is 31,713, and its 52-week low/high is $2.60/$19.375.
Advaxis, Inc. (ADXS) is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete an antigen/adjuvant fusion protein that redirects the powerful immune response all human beings have to fight off cancer and disease.
The company has more than fifteen distinct constructs in various stages of development, all of which are involved in strategic collaborations with recognized centers of excellence such as the National Cancer Institute, Cancer Research – UK, the Wistar Institute, the University of Pennsylvania, the University of British Columbia, the Karolinska Institutet, and others.
Advaxis’ lead construct, ADXS-HPV, is currently in Phase 2 clinical development for recurrent/refractory and advanced cervical cancer, CIN 2/3, and HPV caused head and neck cancers. This important construct was recognized as the Best Therapeutic Vaccine (approved or in development) at the 5th Annual Vaccine Industry Excellence (ViE) Awards by the vaccine industry and the journal Expert Reviews of Vaccines.
The estimated global market for immunotherapies is projected to exceed $37.2B by 2012, with cancer vaccines forecast to grow into an $8B market. Protected by 77 issued and pending patents, Advaxis is extremely well positioned to capitalize on the burgeoning opportunities in the healthcare sector as it advances the development of next-generation treatments for today’s most challenging diseases. Disclaimer
Advaxis, Inc. Company Blog
Advaxis, Inc. News:
Advaxis Lead Product Candidate ADXS-HPV in Combination with PD-1 Antibody Significantly Improves Immune and Therapeutic Efficacy in Preclinical Study
Advaxis Announces Three Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer Annual Meeting
Advaxis Appoints Daniel J. O'Connor President and CEO and Elects Dr. James Patton Non-Executive Chairman of the Board
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.151, up 0.67%, on 162,160 volume with 39 trades. The stock’s average daily volume over the past 60 days is 589,858, and its 52-week low/high is $0.13/$0.41.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation to Present at 12th Annual BIO Investor Forum October 8-9th, 2013
International Stem Cell Corporation to Present New Data From Parkinson's Disease Program at the American Neurological Association 2013 Annual Meeting
International Stem Cell Corporation Advances Parkinson's Disease Program Towards IND Stage
Today's Top 3
Penny Stock Gainers
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Lead Product Candidate ADXS-HPV in Combination with PD-1 Antibody Significantly Improves Immune and Therapeutic Efficacy in Preclinical Study
- Boston Therapeutics, Inc. (BTHE) Closes $5.3 Million in Private Placement of Common Stock and Warrants
- CD International Enterprises, Inc. (CDII) Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders
- Calpian, Inc. (CLPI) Indian Subsidiary Money on Mobile Announces Direct Bill Payment Integration with Indian Utilities Covering Over 25 Million Consumers
- Consorteum Holdings, Inc. (CSRH) Forms a New, Wholly Owned Subsidiary
- DoMark International, Inc. (DOMK) Increases Holding in Imagic Ltd. Ahead of SmartLink Global Launch
- eCrypt Technologies, Inc. (ECRY) Focuses on Immediately Addressable Market
- Epazz Inc. (EPAZ) Short Interest in Market Climbs; Short Interest in Excess of 47 Percent of Total Volume for Sep 2013
- First Titan Corp. (FTTN) Nears Completion of Lucrative New Acquisition
- GlobalWise Investments, Inc. (GWIV) to Participate at the 2013 ANCOR Technology Summit & Showcase
- Intelimax Media, Inc. (IXMD) Launches New Daily Fantasy Sports Platform on DraftTeam.com
- International Stem Cell Corp. (ISCO) to Present at 12th Annual BIO Investor Forum October 8-9th, 2013
- Mabwe Minerals Inc. (MBMI) Launches New Web Site as Affiliate Finalizes Barite Specification Sheets to Commence Barite Qualification
- Max Sound Corp. (MAXD) to Present at Singular's 8th Annual Best of the Uncovereds Conference
- Midwest Energy Emissions Corp. (MEEC) to Present at the Southern California Investor Conference
- NanoTech Entertainment, Inc. (NTEK) 4K Studios Aquires Lasergraphics’ The Director – Ultra HD 4K Film Scanners
- Nexus Enterprise Solutions, Inc. (NXES) Announces Support for Federal Communications Commission Issuance of TCPA Regulations
- On The Move Systems Corp. (OMVS) Negotiates New Referral Agreement to Jump-Start Revenues
- OxySure Systems, Inc. (OXYS) to Exhibit at the National Safety Council's (NSC) 2013 Congress & Expo
- PITOOEY!, Inc. (PTOO) Provides Focused Social Media Advertising
- Raptor Resources Holdings Inc. (RRHI) Mabwe Minerals Launches New Web Site as Affiliate Finalizes Barite Specification Sheets to Commence Barite Qualification
- Sohm, Inc. (SHMN) Announces Engagement of QualityStocks Investor Relations Services
- Singlepoint, Inc. (SING) Announces Engagement of QualityStocks Investor Relations Services
- StreamTrack, Inc. (STTK) Announces Cancellation of Potential $2.5 Million Royalty Liability
- VistaGen Therapeutics, Inc. (VSTA) Provides Update on $36 Million Strategic Financing Agreement